New precision radiation aims to zap prostate tumors while sparing healthy tissue
NCT ID NCT03861676
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new way to deliver radiation implants (brachytherapy) for men with localized prostate cancer. By using advanced imaging (PET/CT and ultrasound) to map only the aggressive tumor areas, doctors hope to target the cancer while leaving healthy tissue untouched, potentially reducing side effects. The study enrolls 20 men with low- to intermediate-risk prostate cancer to see if this focused approach can effectively cover the tumor.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SKCCC at Johns Hopkins
RECRUITINGBaltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can surgery boost control of spread prostate cancer?
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks